High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system
Authors:
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 158, 226-237
Abstract
No abstract availableKeywords
Funding Information
- Institut Pasteur Ebola Task Force
- National Research Foundation of Korea
- Korea government (NRF-2017M3A9G6068246)
This publication has 26 references indexed in Scilit:
- Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell CulturesThe Journal of Infectious Diseases, 2018
- Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry InhibitorsAntimicrobial Agents and Chemotherapy, 2016
- Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor AntagonistsJournal of Virology, 2015
- Novel Small Molecule Entry Inhibitors of Ebola VirusThe Journal of Infectious Diseases, 2015
- High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus ReplicationACS Infectious Diseases, 2015
- Emergence of Zaire Ebola Virus Disease in GuineaNew England Journal of Medicine, 2014
- Reverse genetics systems as tools for the development of novel therapies against filovirusesExpert Review of Anti-infective Therapy, 2014
- Infection of Naïve Target Cells with Virus-Like Particles: Implications for the Function of Ebola Virus VP24Journal of Virology, 2006
- Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for InfectionScience, 2005
- The Properties of Known Drugs. 1. Molecular FrameworksJournal of Medicinal Chemistry, 1996